{Reference Type}: Journal Article
{Title}: A review: Pharmacology and pharmacokinetics of Schisandrin A.
{Author}: Fu K;Zhou H;Wang C;Gong L;Ma C;Zhang Y;Li Y;
{Journal}: Phytother Res
{Volume}: 36
{Issue}: 6
{Year}: Jun 2022
{Factor}: 6.388
{DOI}: 10.1002/ptr.7456
{Abstract}: Schisandrin A (SA) is a bioactive lignan isolated from the traditional Chinese medicine Fructus schisandrae chinensis. In recent years, it has attracted extensive attention because of its multiple pharmacological activities. This review is the first to provide an overview of SA-related pharmacological effects and pharmacokinetic characteristics. The results showed that SA had many pharmacological effects, such as antiinflammation, anticancer, hepatoprotection, antioxidation, neuroprotection, antidiabetes mellitus, and musculoskeletal protection. Among them, NF-κB, Nrf2, MAPK, NLRP3, PI3K/AKT, Wnt, miRNA, P-gp, CYP450, PXR, and other signal transduction pathways are involved. Pharmacokinetic studies showed that SA had good pharmacokinetic characteristics, but these were affected by other factors, such as drugs or hepatic fibrosis. Thus, SA has a variety of pharmacological effects and good pharmacokinetic characteristics, which is worthy of further research and development in the future.